Education & Academic Training:

• 9/96-Present Toledo Cardiology Consultants, Toledo, OH

• 7/95-9/96 Interventional Cardiology Fellowship University of Chicago

• 7/92-6/95 Clinical Cardiology Fellowship University of Missouri

• 7/91-6/92 Chief Resident St. Joseph Mercy Hospital Wayne State University

• 7/89-6/91 Internal Medicine Residency St. Joseph Mercy Hospital Wayne State University

Interventional Experience:

• Diagnostic right and left heart catheterization

• Percutaneous Transluminal Coronary Angioplasty

• Directional Coronary Atherectomy

• Rotational Coronary Atherectomy

• Extraction Coronary Atherectomy

• Coronary Stenting

• Intracoronary Ultrasound Imaging

• Intracoronary Doppler

• Myocardial Biopsy

• Percutaneous Balloon Aortic Valvuloplasty

• Mitral Valvuloplasty

Certification:

• American Board of Internal Medicine American

• American Board of Cardiovascular medicine

• American Board of Interventional Cardiology (eligible)

Medical Licensing:

• Illinois

• Michigan

• Missouri

• California

• Ohio

Honors & Awards:

• American College of Physician Award (Research Category) 10/93 "Abiligy of Beta Blockage to prevent angiotensin II related myocyte necrosis"

• Marion Merrill Dow Research Grant Award

• OHEP Research Recognition Award

• St. Joseph Research Award: (1st & 5th Place)

Membership:

• American Medical Association

• American College of Cardiology

• American College of Physicians

Publications:

• "Catecholamine response to chronic ANG II infusion and its role in myocyte and coronary vascular damage." Am. J. Physiol. 1995. 269:H1569.
   

• "Angiotensin II induced myocyte necrosis: role of the antiotensin II receptors" Cardiovascular Pharma. 1994; 26:547
   

• "Myocardial collagen and its functional role" Book-chapter-28 (Interactive phenomena in the cardiac system.) Adv. Exp. Med. Biol. 1993; 346:291
   

• "Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat." Cardiovasc Research. 1995;29:543
   

• "Ability of beta blocker to prevent angiotensin II related myocyte necrosis" Circulation.1994.904.part2.1712
   

• "Mechanism of angiotensin II related coronary vascular injury in renovascular hypertension." Circulation. 1993;88:4, part 2.I-634
   

• "Ventricular hypertrophy in normal and high renin experimental hypertension" Circulation. 1993;88 4,part 2.I-243
   

• "The ability of low and high dose angiotensin converting enzyme inhibition to prevent angiotensin II related myocyte necrosis." JACC. 1993’21:258A
   

• "Angiotensin converting enzymes inhibition prevent volume-overload left and right ventricular hypertrophy." JACC. 1993;21.258A
   

• "The effect of chronic versus intermittent elevation of plasma angiotensin II on myocyte necrosis." FASEB.J.1993;7:A805
   

• "Angiotensin II induced myocyte necrosis: role of AT1 receptors" J.Mol.Cell.Cardiol.1993;25 (sup III):27
   

• "Prevention of myocyte necrosis in renovascular hypertension using the angiotensin converting enzyme inhibition; Lisinopril." J.Mil.Cell.Cariol.1993;25 (sup III):228